Variables | Men n (%) | Women n (%) | p | Total n (%) |
Number | 43 (43%) | 57 (57%) | 0.08 | 100 |
Average age | 58.7 | 57.83 | 0.043 |
|
Occupation | 28 (65.96%) | 21 (35%) | p < 0.05 | 49 (49%) |
Smoking | 6 (6%) | 2 (2%) | p < 0.001 | 8 (8%) |
Known median duration of diabetes | 6 (0 - 22) | 7 (1 - 4) |
| 74 (74%) |
Hypertension and treatment | ||||
HTA | 35 (57.7%) | 24 (42.2%) | p = 0.095 | 65 (65%) |
Systolic blood pressure | 145.6 (45.7%) | 151.3 (32.3%) | 0.34 | 38 (38%) |
Diastolic blood pressure | 84 (15.2%) | 91 (14.3%) | 0.20 | 14 (14%) |
Diuretics | 3 (1%) | 4 (0.9%) |
| (10.1%) |
ACE inhibitors | 9 (3.1%) | 7 (1.6%) |
| (25.4%) |
Calcium inhibitors | 8 (2.8%) | 10 (2.4%) |
| (27.1%) |
Central | 0 | 2 (0.4%) |
| (1.6%) |
Beta-blockers | 3 (1.05%) | 4 (0.9%) |
| (10.1%) |
Bithérapy | 5 (1.7%) | 6 (1.4%) |
| 10 (16.9%) |
Lipid profile profil lipidique | ||||
Hypertryglyceridaemia | 4 (1.7%) | 8 (4.5%) | 0.4 | 12 (12%) |
Hypo HDL | 13 (5.5%) | 16 (9.1%) | 0.91 | 29 (29%) |
Hyper LDL | 14 (6%) | 18 (10.2%) | 0.45 | 32 (32%) |
Family history diabetes | ||||
Family diabetes | 7 (3%) | 5 (2. 8%) | 0.32 | 12 (12%) |
Stroke | 1 (0.4%) | 2 (1.1%) | 0.4 | 3 (3%) |
Diabetes treatment and glycemic balance | ||||
Metformin | 23 (9.8%) | 42 (23.9%) | 0.001 | 65 (65%) |
Sulfamide | 8 (3.4%) | 6 (3.4%) | 0.32 | 14 (14%) |
Insulin | 4 (1.7%) | 5 (2.8%) | 0.43 | 9 (9%) |
Capillary blood glucose (mg/dl) | 178 | 189 | 0.02 | 183 |
Average glycated hemoglobin | 8.3 | 7.8 |
| 7.99 |